Christopher Visioli
Director of Finance/CFO presso POPULATION HEALTH INVESTMENT CO., INC.
Profilo
Christopher Visioli è direttore finanziario presso Population Health Investment Co., Inc. e direttore finanziario e contabile presso The Medicines Co. Il sig. Visioli è stato precedentemente impiegato come vicepresidente senior della strategia finanziaria di The Medicines Co. Si è laureato alla Cornell University e ha conseguito un MBA alla Columbia Business School.
Posizioni attive di Christopher Visioli
Società | Posizione | Inizio |
---|---|---|
POPULATION HEALTH INVESTMENT CO., INC. | Director of Finance/CFO | 11/09/2020 |
Precedenti posizioni note di Christopher Visioli
Società | Posizione | Fine |
---|---|---|
THE MEDICINES COMPANY | Director of Finance/CFO | 01/05/2020 |
Formazione di Christopher Visioli
Cornell University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Population Health Investment Co., Inc.
Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Christopher Visioli